Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'reverse transcriptase inhibitors' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 361 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Raulin, J
      Human immunodeficiency virus and host cell lipids. Interesting pathways inresearch for a new HIV therapy

      PROGRESS IN LIPID RESEARCH
    2. Pifferi, A; Camalli, M; Silvestri, R; De Martino, G; Massa, S; Artico, M
      1-Amino-6-chloro-2-(1H-pyrrol-2-yl)benzimidazole (RS 1350)

      ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
    3. Lobaton, E; Velazquez, S; San-Felix, A; De Clercq, E; Balzarini, J; Camarasa, MJ
      4 ''-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO family

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    4. Rakotoambinina, B; Medioni, J; Rabian, C; Jubault, V; Jais, JP; Viard, JP
      Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Bogner, JR; Vielhauer, V; Beckmann, RA; Michl, G; Wille, L; Salzberger, B; Goebel, FD
      Stavudine versus zidovudine and the development of lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Mulligan, K; Tai, VW; Algren, H; Abrams, DI; Leiser, RJ; Lo, JC; Schambelan, M
      Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Aggarwal, VK; de Vicente, J; Bonnert, RV
      Catalytic cyclopropanation of alkenes using diazo compounds generated in situ. A novel route to 2-arylcyclopropylamines

      ORGANIC LETTERS
    8. Flepp, M; Schiffer, V; Weber, R; Hirschel, B
      Modern anti-HIV therapy

      SWISS MEDICAL WEEKLY
    9. Pereira, AS; Tidwell, RR
      Separation methods for nucleoside analogues used for treatment of HIV-1 infection

      JOURNAL OF CHROMATOGRAPHY B
    10. Gahan, ME; Miller, F; Lewin, SR; Cherry, CL; Hoy, JF; Mijch, A; Rosenfeldt, F; Wesselingh, SL
      Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction

      JOURNAL OF CLINICAL VIROLOGY
    11. Kislyi, VV; Samet, AV; Semenov, VV
      The utility of nitroacetic acid and its derivatives in the synthesis of heterocycles

      CURRENT ORGANIC CHEMISTRY
    12. White, AJ
      Mitochondrial toxicity and HIV therapy

      SEXUALLY TRANSMITTED INFECTIONS
    13. Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V
      Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up

      ANTIVIRAL THERAPY
    14. Squires, KE
      An introduction to nucleoside and nucleotide analogues

      ANTIVIRAL THERAPY
    15. Garcia-Viejo, MA; Ruiz, M; Martinez, E
      Strategies for treating HIV-related lipodystrophy

      EXPERT OPINION ON INVESTIGATIONAL DRUGS

    16. Phenylthiourea compounds for treating HIV infection - Parker Hughes Institute: WO0078721

      EXPERT OPINION ON THERAPEUTIC PATENTS
    17. Borderi, M; Verucchi, G; Tadolini, M; Spinosa, S; Fortunato, L; Talo, S; Chiodo, F
      Metabolic complications of HIV-1 antiretroviral therapy: The lipodystrophysyndrome

      MICROBIOLOGICA
    18. Dalakas, MC
      Peripheral neuropathy and antiretroviral drugs

      JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
    19. Coghlan, ME; Sommadossi, JP; Jhala, NC; Many, WJ; Saag, MS; Johnson, VA
      Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases

      CLINICAL INFECTIOUS DISEASES
    20. Casimiro-Garcia, A; De Clercq, E; Pannecouque, C; Witvrouw, M; Loftus, TL; Turpin, JA; Buckheit, RW; Fanwick, PE; Cushman, M
      Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments

      BIOORGANIC & MEDICINAL CHEMISTRY
    21. Venkatachalam, TK; Sudbeck, EA; Mao, C; Uckun, FM
      Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    22. Wang, DP; Rizzo, RC; Tirado-Rives, J; Jorgensen, WL
      Antiviral drug design: Computational analyses of the effects of the L100I mutation for HIV-RT on the binding of NNRTIs

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    23. Ludovici, DW; Kukla, MJ; Grous, PG; Krishnan, S; Andries, K; de Bethune, MP; Azijn, H; Pauwels, R; De Clercq, E; Arnold, E; Janssen, PAJ
      Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU)

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    24. Barreca, ML; Chimirri, A; De Luca, L; Monforte, AM; Monforte, P; Rao, A; Zappala, M; Balzarini, J; De Clercq, E; Pannecouque, C; Witvrouw, M
      Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    25. Orlando, C; Gelmini, S
      Telomerase in endocrine and endocrine-dependent tumors

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    26. De Clercq, E
      New developments in anti-HIV chemotherapy

      CURRENT MEDICINAL CHEMISTRY
    27. Togashi, K; Ko, HR; Ahn, JS; Osada, H
      Inhibition of telomerase activity by fungus metabolites, CRM646-A and thielavin B

      BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    28. Zuber, B; Bottiger, D; Benthin, R; Ten Haaft, P; Heeney, J; Wahren, B; Oberg, B
      An in vivo model for HIV resistance development

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    29. Kim, EY; Vrang, L; Oberg, B; Merigan, TC
      Anti-HIV type 1 activity of 3 '-fluoro-3 '-deoxythymidine for several different multidrug-resistant mutants

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    30. Fitzgibbon, JE; Gaur, S; Walsman, SM; Janahi, M; Whitley-Williams, P; John, JF
      Emergence of drug resistance mutations in a group of HIV-infected childrentaking nelfinavir-containing regimens

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    31. Saves, M; Mercie, P; Chene, G
      Lipodystrophic syndrome and antiretroviral treatments in HIV-infected patients

      M S-MEDECINE SCIENCES
    32. Verges, B; Petit, JM
      Lipid anomalies in patients treated with HIV-1 protease inhibitors

      PRESSE MEDICALE
    33. Mauss, S; Schmutz, G
      The HIV-associated lipodystrophy syndrome

      MEDIZINISCHE KLINIK
    34. Bedoya, LM; Sanchez-Palomino, S; Abad, MJ; Bermejo, P; Alcami, J
      Anti-HIV activity of medicinal plant extracts

      JOURNAL OF ETHNOPHARMACOLOGY
    35. Steiner, F; Kind, C; Aebi, LC; Wyler-Lazarevitch, CA; Cheseaux, JJ; Rudin, C; Molinari, L; Nadal, D
      Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitors

      EUROPEAN JOURNAL OF PEDIATRICS
    36. Shulman, N; Zolopa, AR; Passaro, D; Shafer, RW; Huang, W; Katzenstein, D; Israelski, DM; Hellmann, N; Petropoulos, C; Whitcomb, J
      Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy

      AIDS
    37. Ghani, AC; Henley, WE; Donnelly, CA; Mayer, S; Anderson, RM
      Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases

      AIDS
    38. Giaquinto, C; De Romeo, A; Giacomet, V; Rampon, O; Ruga, E; Burlina, A; De Rossi, A; Sturkenboom, M; D'Elia, R
      Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission

      AIDS
    39. van der Valk, M; Gisolf, EH; Reiss, P; Wit, FWNM; Japour, A; Weverling, GJ; Danner, SA
      Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

      AIDS
    40. John, M; Moore, CB; James, IR; Nolan, D; Upton, RP; McKinnon, EJ; Mallal, SA
      Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

      AIDS
    41. Brinkman, K
      Management of hyperlactatemia: no need for routine lactate measurements

      AIDS
    42. Van Laethem, K; Witvrouw, M; Pannecouque, C; Van Remoortel, B; Schmit, JC; Esnouf, R; Kleim, JP; Balzarini, J; Desmyter, J; De Clercq, E; Vandamme, AM
      Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype

      AIDS
    43. Alexander, CS; Dong, W; Chan, K; Jahnke, N; O'Shaughnessy, MV; Mo, T; Piaseczny, MA; Montaner, JSG; Harrigan, PR
      HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort

      AIDS
    44. Miller, V; Vandamme, AM; Loveday, C; Staszewski, S; Lundgren, J; Youle, M; Ait-Khaled, M; Boucher, C; Brun-Vezinet, F; Dedes, N; Giaquinto, C; Hertogs, K; Houyez, F; Perrin, L; Pillay, D; Schmit, JC; Schuurman, R; Lange, J; Banhegyi, D; Biondi, G; Broekhuizen, A; Bush-Donovan, C; Camacho, R; Carlier, H; Clavel, F; Clotet, B; Clumeck, N; Colebunders, R; De Clerq, K; De Jaegher, JJ; De Schrijver, G; De Smet, K; Hall, W; Harrigan, R; Hatzakis, A; Hellmann, N; Hoetelmans, R; Holtzer, C; Katlama, C; Larder, D; Loriaux, E; McCreedy, B; Mulcahy, F; Opravil, M; Phillips, A; Ruiz, N; Shulse, E; Sonnerborg, A; Soriano, V; Steel, H; Vella, S; Williams, A
      Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting

      AIDS
    45. Depairon, M; Chessex, S; Sudre, P; Rodondi, N; Doser, N; Chave, JP; Riesen, W; Nicod, P; Darioli, R; Telenti, A; Mooser, V
      Premature atherosclerosis in HIV-infected individuals - focus on protease inhibitor therapy

      AIDS
    46. Shevitz, A; Wanke, CA; Falutz, J; Kotler, DP
      Clinical perspectives on HIV-associated lipodystrophy syndrome: an update

      AIDS
    47. Nolan, D; Mallal, S
      Getting to the HAART of insulin resistance

      AIDS
    48. Descamps, D; Calvez, V; Izopet, J; Bluffet-Janvresse, C; Schmuck, A; Colson, P; Ruffault, A; Maillard, A; Masquelier, B; Cottalorda, J; Harzic, M; Brun-Vezinet, F; Costagliola, D
      Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study

      AIDS
    49. Shikuma, CM; Hu, N; Milne, C; Yost, F; Waslien, C; Shimizu, S; Shiramizu, B
      Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy

      AIDS
    50. Fagot, JP; Mockenhaupt, M; Bouwes-Bavinck, JN; Naldi, L; Viboud, C; Roujeau, JC
      Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

      AIDS
    51. Zaera, MG; Miro, O; Pedrol, E; Soler, A; Picon, M; Cardellach, F; Casademont, J; Nunes, V
      Mitochondrial involvement in antiretroviral therapy-related lipodystrophy

      AIDS
    52. Foli, A; Benvenuto, F; Piccinini, G; Bareggi, A; Cossarizza, A; Lisziewicz, J; Lori, F
      Direct analysis of mitochondrial toxicity of antiretroviral drugs

      AIDS
    53. Englert, Y; Van Vooren, JP; Place, I; Liesnard, C; Laruelle, C; Delbaere, A
      ART in HIV-infected couples - Has the time come for a change of attitude?

      HUMAN REPRODUCTION
    54. Cossarizza, A; Mussini, C; Vigano, A
      Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?

      BIOESSAYS
    55. Salas-Salvado, J; Garcia-Lorda, P
      The metabolic puzzle during the evolution of HIV infection

      CLINICAL NUTRITION
    56. Wu, JA; Attele, AS; Zhang, L; Yuan, CS
      Anti-HIV activity of medicinal herbs: Usage and potential development

      AMERICAN JOURNAL OF CHINESE MEDICINE
    57. Rowe, TC; Weissig, V; Lawrence, JW
      Mitochondrial DNA metabolism targeting drugs

      ADVANCED DRUG DELIVERY REVIEWS
    58. Tejera, AM; Alonso, DF; Gomez, DE; Olivero, OA
      Chronic in vitro exposure to 3 '-azido-2 ', 3 '-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells

      BREAST CANCER RESEARCH AND TREATMENT
    59. Jain, RG; Furfine, ES; Pedneault, L; White, AJ; Lenhard, JM
      Metabolic complications associated with antiretroviral therapy

      ANTIVIRAL RESEARCH
    60. Chamorro, C; Perez-Perez, MJ; Rodriguez-Barrios, F; Gago, F; De Clercq, E; Balzarini, J; San-Felix, A; Camarasa, MJ
      Exploring the role of the 5 '-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives

      ANTIVIRAL RESEARCH
    61. Yang, SS; Cragg, GM; Newman, DJ; Bader, JP
      Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program

      JOURNAL OF NATURAL PRODUCTS
    62. Izzedine, H; Launay-Vacher, V; Baumelou, A; Deray, G
      An appraisal of antiretroviral drugs in hemodialysis

      KIDNEY INTERNATIONAL
    63. Dykes, C; Fox, K; Lloyd, A; Chiulli, M; Morse, E; Demeter, LM
      Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants

      VIROLOGY
    64. Sales, SD; Hoggard, PG; Sunderland, D; Khoo, S; Hart, CA; Back, DJ
      Zidovudine phosphorylation and mitochondrial toxicity in vitro

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    65. Venkatachalam, TK; Sudbeck, EA; Uckun, FM
      Regiospecific synthesis, X-ray crystal structure and biological activitiesof 5-bromothiophenethyl thioureas

      TETRAHEDRON LETTERS
    66. Petersen, L; Pedersen, EB; Nielsen, C
      Three routes for the synthesis of 6-benzyl-1-ethoxymethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde

      SYNTHESIS-STUTTGART
    67. Janin, YL; Huel, C; Legraverend, M; Aubertin, AM; Bisagni, E
      Syntheses of 4-benzylpyridones via nucleophilic aromatic substitutions

      SYNTHESIS-STUTTGART
    68. De Clercq, E
      New developments in anti-HIV chemotherapy

      PURE AND APPLIED CHEMISTRY
    69. Garcia-Lerma, JG; Nidtha, S; Blumoff, K; Weinstock, H; Heneine, W
      Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    70. Hannongbua, S; Saen-oon, V; Pungpo, P; Wolschann, P
      Molecular calculations on the conformation of the HIV-1 reverse transcriptase inhibitor (+)-(S)-4,5,6,7-tetrahydro-8-chloro-5-methyl-6-(3-methyl-2-butenyl)-imidazo[4,5,1-jk][1,4] benzodiazepine-2(1H)-thione (8-Chloro-TIBO)

      MONATSHEFTE FUR CHEMIE
    71. Lewis, W; Haase, CP; Raidel, SM; Russ, RB; Sutliff, RL; Hoit, BD; Samarel, AM
      Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice

      LABORATORY INVESTIGATION
    72. Orlando, C; Gelmini, S; Selli, C; Pazzagli, M
      Telomerase in urological malignancy

      JOURNAL OF UROLOGY
    73. Gaou, I; Malliti, M; Guimont, MC; Letteron, P; Demeilliers, C; Peytavin, G; Degott, C; Pessayre, D; Fromenty, B
      Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    74. Vlieghe, P; Bihel, F; Clerc, T; Pannecouque, C; Witvrouw, M; De Clercq, E; Salles, JP; Chermann, JC; Kraus, JL
      New 3 '-azido-3 '-deoxythymidin-5 '-yl O-(omega-hydroxyalkyl) carbonate prodrugs: Synthesis and anti-HIV evaluation

      JOURNAL OF MEDICINAL CHEMISTRY
    75. Domingo, P; Matias-Guiu, X; Pujol, RM; Domingo, JC; Arroyo, JA; Sambeat, MA; Vazquez, G
      Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy

      JOURNAL OF INFECTIOUS DISEASES
    76. Burkholder, CR; Dolbier, WR; Medebielle, M
      Synthesis and reactivity of halogeno-difluoromethyl aromatics and heterocycles - Application to the synthesis of gem-difluorinated bioactive compounds

      JOURNAL OF FLUORINE CHEMISTRY
    77. Politzer, P; Murray, JS; Peralta-Inga, Z
      Molecular surface electrostatic potentials in relation to noncovalent interactions in biological systems

      INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY
    78. Gonzalez, OG; Murray, JS; Peralta-Inga, Z; Politzer, P
      Computed molecular surface electrostatic potentials of two groups of reverse transcriptase inhibitors: Relationships to anti-HIV-1 activities

      INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY
    79. Janoff, EN; Smith, PD
      Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management

      GASTROENTEROLOGY
    80. Cirelli, A; Cirelli, G; Scavalli, AS; Masciangelo, R; Marini, M
      Dual-energy X-ray absorptiometry in the early diagnosis of body shape changes in patients with HIV infection treated with nucleoside reverse transcriptase inhibitors and naive to protease inhibitors

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    81. Chaouni-Benabdallah, A; Galtier, C; Allouchi, H; Kherbeche, A; Chavignon, O; Teulade, JC; Witvrouw, M; Pannecouque, C; Snoeck, R; Andrei, G; Balzarini, J; De Clercq, E; Fauvelle, F; Enguehard, C; Gueiffier, A
      3-benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agents

      CHEMICAL & PHARMACEUTICAL BULLETIN
    82. Pinna, GA; Loriga, G; Murineddu, G; Grella, G; Mura, M; Vargiu, L; Murgioni, C; La Colla, P
      Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties

      CHEMICAL & PHARMACEUTICAL BULLETIN
    83. McDermott, AY; Shevitz, A; Knox, T; Roubenoff, R; Kehayias, J; Gorbach, S
      Effect of highly active antiretroviral therapy on fat, lean, and bone massin HIV-seropositive men and women

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    84. Wang, JM; Morin, P; Wang, W; Kollman, PA
      Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    85. Groschel, B; Spielhofen, A; Sturmer, M; Cinatl, J; Doerr, HW
      Diagnosis of resistance in the treatment of AIDS: clarification of viral and cellular factors

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    86. van der Ende, ME; Guillon, C; Boers, PHM; Ly, TD; Gruters, RA; Osterhaus, ADME; Schutten, M
      Antiviral resistance of biologic HIV-2 clones obtained from individuals onnucleoside reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    87. Girard, PM; Pegram, PS; Diquet, B; Anderson, R; Raffi, F; Tubiana, R; Sereni, D; Boerner, D
      Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection:Pharmacokinetics, tolerability, and efficacy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    88. Morlat, P; Marimoutou, C; Dequae-Merchadou, L; Pellegrin, I; Mercie, I; Neau, D; Beylot, J; Dabis, F
      Dual nucleoside regimens in nonadvanced HIV infection: Prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    89. Sluis-Cremer, N; Arion, D; Parniak, MA
      Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)

      CELLULAR AND MOLECULAR LIFE SCIENCES
    90. Aymard, G; Legrand, M; Trichereau, N; Diquet, B
      Determination of twelve antiretroviral agents in human plasma sample usingreversed-phase high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    91. Van Calenbergh, S; Herdewijn, P
      A heterogeneous collection of novel antiviral pyrimidines

      EXPERT OPINION ON THERAPEUTIC PATENTS
    92. Wimer, BM; Mann, PL
      Mitogen immunotherapy for HIV infections exemplified by phytohemagglutininand pokeweed mitogen

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    93. Sbardella, G; Mai, A; Artico, M; Massa, S; Marceddu, T; Vargiu, L; Marongiu, ME; La Colla, P
      Does the 2-methylthiomethyl substituent really confer high anti-HIV-1 activity to S-DABOS?

      MEDICINAL CHEMISTRY RESEARCH
    94. De Clercq, E
      Novel compounds in preclinical/early clinical development for the treatment of HIV infections

      REVIEWS IN MEDICAL VIROLOGY
    95. Casimiro-Garcia, A; De Clercq, E; Pannecouque, C; Witvrouw, M; Stup, TL; Turpin, JA; Buckheit, RW; Cushman, M
      Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain

      BIOORGANIC & MEDICINAL CHEMISTRY
    96. Silvestri, R; Artico, M; Massa, S; Marceddu, T; De Montis, F; La Colla, P
      1-[2-(Diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazole: a potent lead for the design of novel NNRTIs

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    97. Kelland, LR
      Telomerase inhibitors: targeting the vulnerable end of cancer?

      ANTI-CANCER DRUGS
    98. ter Hofstede, HJM; de Marie, D; Foudraine, NA; Danner, SA; Brinkman, K
      Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases

      INTERNATIONAL JOURNAL OF STD & AIDS
    99. Richard, N; Salomon, H; Oliveira, M; Rando, R; Mansour, T; Gu, ZX; Wainberg, MA
      Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    100. Buckheit, RW; Russell, JD; Xu, ZQ; Flavin, M
      Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/10/20 alle ore 22:38:18